Join us for an insightful webinar exploring the transformative impact of digitalization and automation on pharmaceutical R&D and manufacturing. Discover how cutting-edge data capture, centralization, and standardization techniques are creating AI-ready data, paving the way for groundbreaking advancements in drug discovery, development, and production. We’ll also delve into how automating traditionally manual tasks enhances efficiency, minimizes errors, and ensures seamless data flow between R&D and manufacturing. This accelerates the delivery of personalized medicines while significantly reducing costs.
Learn how well integrated digital solutions can drive your digital transformation and optimize your R&D and manufacturing processes!
November 20, 2024 | 11:00 a.m. EST
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciY
Anna has a degree in Chemistry and a Ph.D. in Protein NMR from the University of Barcelona, Spain. She undertook her post-doc in protein NMR at the MRC Laboratory of Molecular Biology in Cambridge, UK, and following that worked in the Analytical R&D department of Pfizer for seven years, becoming proficient in low level impurity structure elucidation, reaction monitoring, qNMR and the preparation of regulatory documentation. She received a Pfizer Worldwide Achievement Award for the implementation of reaction monitoring by NMR in an open access environment.
She joined Bruker in 2011 and had different roles since including Material Characterisation Laboratory Manager, Product Portfolio Manager and for several years was in charge of driving the Biopharmaceutical business at Bruker BioSpin. Anna recently moved to SciY as Senior Director of Strategy and Business Development.